为对比扎韦格潘（zavegepant）与口服 CGRP 受体拮抗剂治疗偏头痛的效果，研究发现前者起效快但长期优势不明显。 偏头痛，这种让人痛苦不堪的神经系统疾病，如同一个隐藏在暗处的 “小恶魔”，常常突然发起攻击。它以单侧或双侧搏动性头痛为典型特征 ...

Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...

as well as daily oral CGRP drugs like Biohaven's Nurtec ODT (rimegepant) and AbbVie's recently approved Qulipta (atogepant). While patients may not consider Vyepti's IV formulation to be as ...